| For: | Mao QY, Ran H, Hu QY, He SY, Lu Y, Li H, Chai YM, Chu ZY, Qian X, Ding W, Niu YX, Zhang HM, Li XY, Su Q. Impaired efferocytosis by monocytes and monocyte-derived macrophages in patients with poorly controlled type 2 diabetes. World J Diabetes 2025; 16(5): 101473 [PMID: 40487610 DOI: 10.4239/wjd.v16.i5.101473] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i5/101473.htm |
| Number | Citing Articles |
| 1 |
Yanqi Lei, Min Tang, Huilan Deng, Yanqun Li, Jidi Wu, Li Luo, Yulin Mou, Qianshi Wu, Qifu Li, Yong Xu, Wei Huang. Defective efferocytosis in diabetes: molecular mechanisms and emerging therapeutic strategies. Inflammation Research 2026; 75(1) doi: 10.1007/s00011-026-02302-w
|
| 2 |
Dongze Li, Yao Huang, Xuanqin Chen, Li Zhang, Qiming Gong, Qifu Li, Yu Li, Yong Xu, Wei Huang. Efferocytosis: unifying pathogenic hub in metabolic disorders—mechanistic landscapes, targeted therapies and translational bottlenecks. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1886016
|
| 3 |
Yi Song, Jiayi Yuan, Yifan Li, Yifan Liu, Guijun Qin. Efferocytosis: a therapeutic strategy for diabetes and its vascular complications. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1641748
|
| 4 |
Dania Al‐Sharify, Jiangming Sun, Andreas Edsfeldt. The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities. Journal of Internal Medicine 2026; 300(2) doi: 10.1111/joim.70118
|
| 5 |
Bingxin Huangfu, Jia Xu, Xianghui Huang, Kunlun Huang, Xiaoyun He, Baiqiang Zhai. The Crosstalk
Between Macrophages and Hepatic Energy
Metabolic Reprogramming and the Modulation by Natural Products: An
Overview. ACS Nutrition Science 2026; doi: 10.1021/acsnutrsci.6c00050
|
| 6 |
Keivan Sahebi, Maedeh Bordbar, Saghi Eslamzadeh, Fatemeh Hosseinpour-Soleimani, Amir Tajbakhsh, Amir Savardashtaki, Armin Attar. Macrophage trafficking and efferocytosis in atherosclerotic plaque regression: Molecular mechanisms and therapeutic perspectives. Biomedicine & Pharmacotherapy 2026; 203 doi: 10.1016/j.biopha.2026.119872
|